Protalix BioTherapeutics
PLX
#8725
Rank
โ‚น22.98 B
Marketcap
โ‚น272.61
Share price
1.75%
Change (1 day)
44.28%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): โ‚น2.32 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚น80.61 Million. In 2025 the company made an earning of -โ‚น0.4 Billion a decrease over its 2024 earnings that were of โ‚น0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.32 B-682.67%
2025 -โ‚น0.4 Billion-181.6%
2024 โ‚น0.48 B-55.62%
2023 โ‚น1.10 B-199.05%
2022 -โ‚น1.12 Billion-40.38%
2021 -โ‚น1.87 Billion-732.31%
2020 โ‚น0.29 B-130.53%
2019 -โ‚น0.97 Billion189.85%
2018 -โ‚น0.34 Billion-95.29%
2017 -โ‚น7.08 Billion308.12%
2016 -โ‚น1.74 Billion-32.37%
2015 -โ‚น2.57 Billion10.11%
2014 -โ‚น2.33 Billion-7.59%
2013 -โ‚น2.52 Billion
2011 -โ‚น2.92 Billion-19.39%
2010 -โ‚น3.62 Billion20.87%
2009 -โ‚น3 Billion32.26%
2008 -โ‚น2.27 Billion-5.46%
2007 -โ‚น2.4 Billion
2004 -โ‚น15.52 Million12.35%
2003 -โ‚น13.81 Million-11.1%
2002 -โ‚น15.54 Million-57.03%
2001 -โ‚น36.15 Million1.03%
2000 -โ‚น35.78 Million-53.22%
1999 -โ‚น76.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น652.76 B 28,094.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น80.84 B 3,391.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น17.89 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น114.66 B 4,852.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel